Purple Biotech Ltd. SEC filings PPBT
Purple Biotech Ltd. has 576 filings in SEC EDGAR's recent list, going back to Aug 18, 2014. Its latest annual report, Form 20-F, was filed on Mar 19, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 5, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| F-3 | Shelf registration (foreign issuer) | May 20, 2026 | — |
| 424B5 | Prospectus supplement | Sep 19, 2025 | — |
| 424B4 | Prospectus | Sep 5, 2025 | — |
| F-1 | Registration statement (foreign issuer) | Aug 29, 2025 | — |
| 424B5 | Prospectus supplement | Jan 6, 2025 | — |
| 424B5 | Prospectus supplement | Dec 4, 2024 | — |
| 424B3 | Prospectus | Jul 31, 2024 | — |
| F-1 | Registration statement (foreign issuer) | Jul 22, 2024 | — |
| 424B3 | Prospectus | Jul 2, 2024 | — |
| POS AM | Post-effective amendment no. 1 to form f-1 | Mar 28, 2024 | — |
| 424B3 | Prospectus | Nov 14, 2023 | — |
| F-1/A | Amendment no. 1 to form f-1 | Nov 13, 2023 | — |
| F-1 | Registration statement (foreign issuer) | Oct 30, 2023 | — |
| 424B3 | Prospectus | Oct 19, 2023 | — |
| 424B5 | Prospectus supplement | Oct 19, 2023 | — |
| 424B5 | Prospectus supplement | Oct 17, 2023 | — |
| F-3/A | Amendment no. 1 to form f-3 | May 17, 2023 | — |
| 424B3 | Prospectus | Apr 5, 2023 | — |
| 424B3 | Prospectus | Apr 3, 2023 | — |
| F-3 | Shelf registration (foreign issuer) | Mar 23, 2023 | — |
| F-3 | Shelf registration (foreign issuer) | Dec 8, 2022 | — |
| S-8 | Employee stock plan registration | Apr 4, 2022 | — |
| 424B5 | Prospectus supplement | Mar 23, 2022 | — |
| 424B5 | Prospectus supplement | Jun 9, 2021 | — |
| POS AM | Post-effective amendment no. 1 | Jul 10, 2020 | — |
| F-3 | Shelf registration (foreign issuer) | Jul 10, 2020 | — |
| 424B5 | Prospectus supplement | Jun 25, 2020 | — |
| S-8 | Employee stock plan registration | May 18, 2020 | — |
| F-3 | Shelf registration (foreign issuer) | May 13, 2020 | — |
| 424B5 | Prospectus supplement | May 8, 2020 | — |
| 424B4 | Prospectus | Mar 16, 2020 | — |
| F-1/A | Amendment no. 2 to registration statement | Mar 11, 2020 | — |
| F-1/A | Amendment no. 1 to form f-1 | Mar 10, 2020 | — |
| 424B3 | Prospectus | Dec 27, 2019 | — |
| F-1 | Registration statement (foreign issuer) | Dec 27, 2019 | — |
| F-3 | Shelf registration (foreign issuer) | Dec 2, 2019 | — |
| 424B3 | Prospectus | Oct 2, 2019 | — |
| F-3 | Shelf registration (foreign issuer) | Sep 16, 2019 | — |
| F-1 | Registration statement (foreign issuer) | Sep 16, 2019 | — |
| S-8 | Employee stock plan registration | Mar 28, 2019 | — |
| 424B5 | Prospectus supplement | Jan 18, 2019 | — |
| 424B3 | Prospectus | Jan 4, 2019 | — |
| F-3/A | Amendment no. 1 to form f-3 | Aug 3, 2018 | — |
| F-3 | Shelf registration (foreign issuer) | Jul 16, 2018 | — |
| 424B5 | Prospectus supplement | Jun 5, 2018 | — |
| 424B3 | Prospectus | Jan 31, 2018 | — |
| 424B5 | Prospectus supplement | Jul 13, 2017 | — |
| S-8 | Employee stock plan registration | Jun 6, 2017 | — |
| POS AM | Post-effective amendment no. 2 to form f-1 | Dec 12, 2016 | — |
| POS AM | Post-effective amendment no. 2 to form f-1 | Dec 12, 2016 | — |
| F-3 | Shelf registration (foreign issuer) | Dec 12, 2016 | — |
| POS AM | Post-effective amendment no. 1 to form f-1 | Nov 28, 2016 | — |
| POS AM | Post-effective amendment no. 2 to form f-1 | Nov 28, 2016 | — |
| F-3 | Shelf registration (foreign issuer) | Nov 28, 2016 | — |
| 424B3 | Prospectus | Sep 30, 2016 | — |
| 424B3 | Prospectus | Sep 30, 2016 | — |
| 424B3 | Prospectus | Jul 22, 2016 | — |
| 424B4 | Prospectus | Jul 1, 2016 | — |
| F-1MEF | Filing | Jun 29, 2016 | — |
| F-1/A | Filing | Jun 28, 2016 | — |
| F-1/A | Filing | Jun 27, 2016 | — |
| S-8 | Employee stock plan registration | May 20, 2016 | — |
| F-1 | Registration statement (foreign issuer) | May 20, 2016 | — |
| 424B3 | Prospectus | May 16, 2016 | — |
| POS AM | Filing | Mar 18, 2016 | — |
| 424B3 | Prospectus | Dec 16, 2015 | — |
| 424B4 | Prospectus | Nov 23, 2015 | — |
| F-1MEF | Filing | Nov 20, 2015 | — |
| F-1/A | Filing | Nov 20, 2015 | — |
| F-1/A | Filing | Nov 19, 2015 | — |
| F-1/A | Filing | Nov 18, 2015 | — |
| FWP | Free writing prospectus | Nov 12, 2015 | — |
| F-1/A | Filing | Nov 6, 2015 | — |
| F-6 | Form f-6 | Nov 6, 2015 | — |
| F-1 | Registration statement (foreign issuer) | Sep 24, 2015 | — |
Showing 75 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PPBT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Rehovot, Israel
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1614744
- Former names
- Kitov Pharma Ltd. (until Dec 10, 2020); Kitov Pharmaceuticals Holdings Ltd. (until Dec 21, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.